Provided by Tiger Trade Technology Pte. Ltd.

Abbott Laboratories

116.64
+2.502.19%
Post-market: 116.12-0.5226-0.45%19:59 EDT
Volume:9.93M
Turnover:1.15B
Market Cap:202.82B
PE:37.74
High:116.66
Open:114.02
Low:113.45
Close:114.14
52wk High:137.49
52wk Low:81.97
Shares:1.74B
Float Shares:1.70B
Volume Ratio:1.24
T/O Rate:0.58%
Dividend:2.48
Dividend Rate:2.13%
EPS(TTM):3.09
EPS(LYR):3.73
ROE:10.58%
ROA:5.33%
PB:3.97
PE(LYR):31.27

Loading ...

Jul 16, 2020

Major Issues Report

8-K - Current report
Jun 26, 2020

Employee Stock Ownership

11-K - Annual report of employee stock purchase, savings and similar plans
Jun 24, 2020

Major Issues Report

8-K - Current report
Jun 22, 2020

[Supp]Public Prospectus

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Apr 29, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 28, 2020

Major Issues Report

8-K - Current report
Apr 16, 2020

Major Issues Report

8-K - Current report
Feb 27, 2020

Major Issues Report

8-K - Current report
Feb 21, 2020

Annual Report

Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 12, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 11, 2020

Major Issues Report

Current report, item 5.02
Feb 05, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Jan 22, 2020

Major Issues Report

Current report, items 2.02 and 9.01
Jan 08, 2020

Major Issues Report

Current report, item 5.02
Dec 19, 2019

Major Issues Report

Current report, items 1.02, 2.04, and 8.01
Nov 19, 2019

Statement Of Changes In Beneficial Ownership

Initial statement of beneficial ownership of securities
Nov 19, 2019

Major Issues Report

Current report, items 8.01 and 9.01
Nov 13, 2019

Major Issues Report

Current report, items 5.02, 5.03, and 9.01
Nov 12, 2019

Major Issues Report

Current report, item 8.01